| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse
|
Faude, Sophia
|
|
|
|
8 |
p. 2128-2136
|
artikel
|
| 2 |
A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells
|
Kovtun, Yelena
|
|
|
|
8 |
p. 848-858
|
artikel
|
| 3 |
A cross-sectional study of prevalence, distribution, cause, and impact of blood product recalls in the United States
|
Alqemlas, Ibrahim
|
|
|
|
8 |
p. 1780-1791
|
artikel
|
| 4 |
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs
|
Balliu, Manjola
|
|
|
|
8 |
p. 2184-2195
|
artikel
|
| 5 |
Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency
|
Ramdeny, Sandheeah
|
|
|
|
8 |
p. 2153-2155
|
artikel
|
| 6 |
A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b
|
Zhou, Hua
|
|
|
|
8 |
p. 504-515
|
artikel
|
| 7 |
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults
|
DeBaun, M.R.
|
|
|
|
8 |
p. 1554-1588
|
artikel
|
| 8 |
A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis
|
Sohn, Jihee
|
|
|
|
8 |
p. 2557-2577
|
artikel
|
| 9 |
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations
|
Levis, Mark J.
|
|
|
|
8 |
p. 825-831
|
artikel
|
| 10 |
An intracytoplasmic β3 Leu718 deletion in a patient with a novel platelet phenotype
|
Nurden, Paquita
|
|
|
|
8 |
p. 494-499
|
artikel
|
| 11 |
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML
|
Mason, Emily F.
|
|
|
|
8 |
p. 2279-2283
|
artikel
|
| 12 |
A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study
|
Wagner, Sarah
|
|
|
|
8 |
p. 1330-1346
|
artikel
|
| 13 |
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
|
Lancet, Jeffrey E.
|
|
|
|
8 |
p. 1683-1689
|
artikel
|
| 14 |
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD–mutant acute myeloid leukemia
|
Smith, Catherine C.
|
|
|
|
8 |
p. 1711-1721
|
artikel
|
| 15 |
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
|
Schroeder, Mark A.
|
|
|
|
8 |
p. 1656-1669
|
artikel
|
| 16 |
Approaching the crisis in medical research funding: an important role for nonprofit organizations and medical societies
|
Abkowitz, Janis L.
|
|
|
|
8 |
p. 846-847
|
artikel
|
| 17 |
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment
|
Jensen, Paw
|
|
|
|
8 |
p. 2549-2556
|
artikel
|
| 18 |
A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD
|
Kloosterman, Robert
|
|
|
|
8 |
p. 1477-1487
|
artikel
|
| 19 |
Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy
|
Bezerra, Evandro D.
|
|
|
|
8 |
p. 1572-1576
|
artikel
|
| 20 |
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
|
Nakajima, Reiko
|
|
|
|
8 |
p. 1812-1823
|
artikel
|
| 21 |
Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature
|
Chan, Maverick
|
|
|
|
8 |
p. 1756-1759
|
artikel
|
| 22 |
Bornhauser B, Cario G, Rinaldi A, et al. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL. Blood Adv. 2020;4(17):4052-4064.
|
|
|
|
|
8 |
p. 2700
|
artikel
|
| 23 |
Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?
|
Prod'homme, Chloé
|
|
|
|
8 |
p. 2123-2127
|
artikel
|
| 24 |
Can somatic GATA2 mutation mimic germ line GATA2 mutation?
|
Sekhar, Mallika
|
|
|
|
8 |
p. 904-908
|
artikel
|
| 25 |
Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis
|
Peyvandi, Flora
|
|
|
|
8 |
p. 2137-2141
|
artikel
|
| 26 |
CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking
|
Barker, Juliet N.
|
|
|
|
8 |
p. 1267-1271
|
artikel
|
| 27 |
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies
|
Patel, Anand A.
|
|
|
|
8 |
p. 2264-2271
|
artikel
|
| 28 |
Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD
|
Dupervil, Brandi
|
|
|
|
8 |
p. 2079-2086
|
artikel
|
| 29 |
Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies
|
Peterson, Jess F.
|
|
|
|
8 |
p. 1298-1302
|
artikel
|
| 30 |
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
|
Lakhotia, Rahul
|
|
|
|
8 |
p. 2667-2680
|
artikel
|
| 31 |
Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience
|
Katamesh, Bahga
|
|
|
|
8 |
p. 1351-1355
|
artikel
|
| 32 |
Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients
|
Qdaisat, Aiham
|
|
|
|
8 |
p. 1606-1614
|
artikel
|
| 33 |
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients
|
Li, Marissa
|
|
|
|
8 |
p. 2272-2278
|
artikel
|
| 34 |
Clinical value of event-free survival in acute myeloid leukemia
|
Maiti, Abhishek
|
|
|
|
8 |
p. 1690-1699
|
artikel
|
| 35 |
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
|
Ramaswamy, Kavitha
|
|
|
|
8 |
p. 2688-2694
|
artikel
|
| 36 |
Coagulation factor XII contributes to hemostasis when activated by soil in wounds
|
Juang, Lih Jiin
|
|
|
|
8 |
p. 1737-1745
|
artikel
|
| 37 |
Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis
|
Aljama, Mohammed A.
|
|
|
|
8 |
p. 1226-1229
|
artikel
|
| 38 |
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report
|
Balas, Nora
|
|
|
|
8 |
p. 2471-2479
|
artikel
|
| 39 |
CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma
|
Shamay, Meir
|
|
|
|
8 |
p. 1624-1627
|
artikel
|
| 40 |
CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma
|
Guo, Yelei
|
|
|
|
8 |
p. 2695-2699
|
artikel
|
| 41 |
Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia
|
Braunstein, Zachary
|
|
|
|
8 |
p. 2685-2687
|
artikel
|
| 42 |
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD
|
Bejanyan, Nelli
|
|
|
|
8 |
p. 909-922
|
artikel
|
| 43 |
Development of BRAFV600E -positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH
|
Salek, Marta
|
|
|
|
8 |
p. 2681-2684
|
artikel
|
| 44 |
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL
|
Kurahashi, Yuki
|
|
|
|
8 |
p. 1545-1559
|
artikel
|
| 45 |
Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in mice
|
Willis, Alexander J.
|
|
|
|
8 |
p. 1418-1431
|
artikel
|
| 46 |
Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling
|
Theofani, Efthymia
|
|
|
|
8 |
p. 877-882
|
artikel
|
| 47 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 48 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 49 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 50 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 51 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 52 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 53 |
Editorial Board
|
|
|
|
|
8 |
p. i
|
artikel
|
| 54 |
Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity
|
Zheng, Tony J.
|
|
|
|
8 |
p. 1366-1378
|
artikel
|
| 55 |
Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma
|
Patrick, Donald L.
|
|
|
|
8 |
p. 2245-2255
|
artikel
|
| 56 |
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis
|
Jeong, Hyehyun
|
|
|
|
8 |
p. 2142-2152
|
artikel
|
| 57 |
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
|
Buccisano, Francesco
|
|
|
|
8 |
p. 2510-2516
|
artikel
|
| 58 |
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias
|
Fan, Xing
|
|
|
|
8 |
p. 1700-1710
|
artikel
|
| 59 |
Eshel A, Sharon I, Nagler A, et al. Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. Blood Adv. 2022;6(2):568-573.
|
|
|
|
|
8 |
p. 2578-2580
|
artikel
|
| 60 |
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
|
Iwasaki, Makoto
|
|
|
|
8 |
p. 2618-2627
|
artikel
|
| 61 |
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy
|
Rodríguez-Sevilla, Juan Jose
|
|
|
|
8 |
p. 1606-1614
|
artikel
|
| 62 |
EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis
|
Yamaoka, Ayaka
|
|
|
|
8 |
p. 1722-1736
|
artikel
|
| 63 |
EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
|
Masamoto, Yosuke
|
|
|
|
8 |
p. 1577-1593
|
artikel
|
| 64 |
Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis
|
Osataphan, Soravis
|
|
|
|
8 |
p. 2055-2062
|
artikel
|
| 65 |
Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential
|
Nakajima, Yuto
|
|
|
|
8 |
p. 1436-1445
|
artikel
|
| 66 |
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia
|
Strahm, Brigitte
|
|
|
|
8 |
p. 1760-1769
|
artikel
|
| 67 |
Fedratinib in myelofibrosis
|
Mullally, Ann
|
|
|
|
8 |
p. 1792-1800
|
artikel
|
| 68 |
Ferrari N, Ward G, Gewinner C, et al. Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma. Blood Adv. 2021;5(20):4003-4016.
|
|
|
|
|
8 |
p. 2548
|
artikel
|
| 69 |
Front Matter
|
|
|
|
|
8 |
p. ii
|
artikel
|
| 70 |
Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
|
Martin, Paul J.
|
|
|
|
8 |
p. 2608-2617
|
artikel
|
| 71 |
Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia
|
Jiang, Chuang
|
|
|
|
8 |
p. 2496-2509
|
artikel
|
| 72 |
Glia maturation factor-γ regulates murine macrophage iron metabolism and M2 polarization through mitochondrial ROS
|
Aerbajinai, Wulin
|
|
|
|
8 |
p. 1211-1225
|
artikel
|
| 73 |
Guerrero CLH, Yamashita Y, Miyara M, et al. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL. Blood Adv. 2020;4(6):1062-1071.
|
|
|
|
|
8 |
p. 1647
|
artikel
|
| 74 |
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
|
DeZern, Amy E.
|
|
|
|
8 |
p. 1770-1779
|
artikel
|
| 75 |
Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
|
Mehta, Rohtesh S.
|
|
|
|
8 |
p. 1594-1603
|
artikel
|
| 76 |
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
|
Stahl, Maximilian
|
|
|
|
8 |
p. 923-932
|
artikel
|
| 77 |
IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis
|
Sidana, Surbhi
|
|
|
|
8 |
p. 2101-2105
|
artikel
|
| 78 |
IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer
|
Furlan, Scott N.
|
|
|
|
8 |
p. 1594-1605
|
artikel
|
| 79 |
Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA
|
Rutherford, Sarah C.
|
|
|
|
8 |
p. 1589-1593
|
artikel
|
| 80 |
Impact of exercise on the immune system and outcomes in hematologic malignancies
|
Sitlinger, Andrea
|
|
|
|
8 |
p. 1801-1811
|
artikel
|
| 81 |
Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
|
Ueda Oshima, Masumi
|
|
|
|
8 |
p. 1394-1403
|
artikel
|
| 82 |
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax
|
Lachowiez, Curtis A.
|
|
|
|
8 |
p. 2173-2183
|
artikel
|
| 83 |
Impact of the ICAL on the treatment of acute leukemia
|
Rego, Eduardo M.
|
|
|
|
8 |
p. 516
|
artikel
|
| 84 |
Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
|
Joelsson, Joel
|
|
|
|
8 |
p. 2657-2666
|
artikel
|
| 85 |
Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation
|
Ram, Jodi
|
|
|
|
8 |
p. 500-503
|
artikel
|
| 86 |
Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma
|
Maziarz, Richard T.
|
|
|
|
8 |
p. 2536-2547
|
artikel
|
| 87 |
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP
|
Eyre, Toby A.
|
|
|
|
8 |
p. 2229-2236
|
artikel
|
| 88 |
Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified
|
Nakayama, Shoko
|
|
|
|
8 |
p. 486-493
|
artikel
|
| 89 |
Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis
|
Dykstra, Kaitlyn M.
|
|
|
|
8 |
p. 2087-2100
|
artikel
|
| 90 |
Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia
|
van Vuren, Annelies.J.
|
|
|
|
8 |
p. 1678-1682
|
artikel
|
| 91 |
Karihtala K, Leivonen S-K, Karjalainen-Lindsberg M-L, et al. Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients. Blood Adv. 2022;6(6):1919-1931.
|
|
|
|
|
8 |
p. 1432-1435
|
artikel
|
| 92 |
Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma
|
Ménard, Cédric
|
|
|
|
8 |
p. 2063-2074
|
artikel
|
| 93 |
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system
|
Cani, Alice
|
|
|
|
8 |
p. 1513-1524
|
artikel
|
| 94 |
Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia
|
Mahat, Upendra
|
|
|
|
8 |
p. 2581-2594
|
artikel
|
| 95 |
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
|
Bohlius, Julia
|
|
|
|
8 |
p. 1197-1210
|
artikel
|
| 96 |
M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion
|
Luo, Yi
|
|
|
|
8 |
p. 859-870
|
artikel
|
| 97 |
MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity
|
Schütze, Kerstin
|
|
|
|
8 |
p. 1531-1535
|
artikel
|
| 98 |
Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice
|
Couvidou, Adèle
|
|
|
|
8 |
p. 1356-1365
|
artikel
|
| 99 |
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression
|
Walker, Zachary J.
|
|
|
|
8 |
p. 1628-1639
|
artikel
|
| 100 |
Metabolomic and molecular insights into sickle cell disease and innovative therapies
|
Adebiyi, Morayo G.
|
|
|
|
8 |
p. 1347-1355
|
artikel
|
| 101 |
Minor PNH clones do not distinguish inherited bone marrow failure syndromes from immune-mediated aplastic anemia
|
Narita, Atsushi
|
|
|
|
8 |
p. 2517-2519
|
artikel
|
| 102 |
MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing
|
Schneidawind, Corina
|
|
|
|
8 |
p. 832-845
|
artikel
|
| 103 |
Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development
|
Hernandez, Jose A.
|
|
|
|
8 |
p. 1244-1254
|
artikel
|
| 104 |
Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in mice
|
Sonkar, Vijay K.
|
|
|
|
8 |
p. 1272-1284
|
artikel
|
| 105 |
Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice
|
Keleku-Lukwete, Nadine
|
|
|
|
8 |
p. 1285-1297
|
artikel
|
| 106 |
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
|
Scordo, Michael
|
|
|
|
8 |
p. 1536-1544
|
artikel
|
| 107 |
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
|
Kinoshita, Hannah
|
|
|
|
8 |
p. 2520-2534
|
artikel
|
| 108 |
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
|
Shah, Nirav N.
|
|
|
|
8 |
p. 933-940
|
artikel
|
| 109 |
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes
|
Ward, Grace A.
|
|
|
|
8 |
p. 2216-2228
|
artikel
|
| 110 |
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling
|
Greene, J.T.
|
|
|
|
8 |
p. 1255-1266
|
artikel
|
| 111 |
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
|
Zeidan, Amer M.
|
|
|
|
8 |
p. 1615-1623
|
artikel
|
| 112 |
Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study
|
Muffly, Lori
|
|
|
|
8 |
p. 895-903
|
artikel
|
| 113 |
Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
|
Lundgren, Taran S.
|
|
|
|
8 |
p. 2628-2645
|
artikel
|
| 114 |
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
|
Kumar, Anita
|
|
|
|
8 |
p. 871-876
|
artikel
|
| 115 |
Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?
|
Agbani, Ejaife O.
|
|
|
|
8 |
p. 1615-1619
|
artikel
|
| 116 |
Platelet SHARPIN regulates platelet adhesion and inflammatory responses through associations with αIIbβ3 and LUBAC
|
Kasirer-Friede, Ana
|
|
|
|
8 |
p. 2595-2607
|
artikel
|
| 117 |
Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics
|
Migdady, Yazan
|
|
|
|
8 |
p. 2707-2721
|
artikel
|
| 118 |
Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma
|
van der Horst, Hilma J.
|
|
|
|
8 |
p. 2165-2172
|
artikel
|
| 119 |
Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research: DRIVE
|
Birhiray, Maya N.
|
|
|
|
8 |
p. 1507-1512
|
artikel
|
| 120 |
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
|
Verkleij, Christie P.M.
|
|
|
|
8 |
p. 2196-2215
|
artikel
|
| 121 |
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
|
Köksal, Hakan
|
|
|
|
8 |
p. 1230-1243
|
artikel
|
| 122 |
Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study
|
Qi, Shunan
|
|
|
|
8 |
p. 1496-1506
|
artikel
|
| 123 |
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years
|
van Zeventer, Isabelle A.
|
|
|
|
8 |
p. 2115-2122
|
artikel
|
| 124 |
Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels
|
Au, Amanda E.
|
|
|
|
8 |
p. 1560-1571
|
artikel
|
| 125 |
Promoting platelets is a therapeutic option to combat severe viral infection of the lung
|
Qiu, Jiahuang
|
|
|
|
8 |
p. 1640-1642
|
artikel
|
| 126 |
Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation
|
Kong, Yuan
|
|
|
|
8 |
p. 1303-1317
|
artikel
|
| 127 |
13q12.2 deletions and FLT3 overexpression in acute leukemias
|
Poubel, Caroline Pires
|
|
|
|
8 |
p. 2075-2078
|
artikel
|
| 128 |
Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity
|
Carew, Jennifer S.
|
|
|
|
8 |
p. 1318-1329
|
artikel
|
| 129 |
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
|
Azhar, Mohammad
|
|
|
|
8 |
p. 1460-1476
|
artikel
|
| 130 |
Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors
|
Nagelkerke, Sietse Q.
|
|
|
|
8 |
p. 941-953
|
artikel
|
| 131 |
Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan
|
Hato, Takaaki
|
|
|
|
8 |
p. 1648-1655
|
artikel
|
| 132 |
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
|
Mohan, Meera
|
|
|
|
8 |
p. 2466-2470
|
artikel
|
| 133 |
Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
|
Younes, Anas
|
|
|
|
8 |
p. 1488-1495
|
artikel
|
| 134 |
Should minimal residual disease negativity be the end point of myeloma therapy?
|
Anderson, Kenneth C.
|
|
|
|
8 |
p. 517-521
|
artikel
|
| 135 |
Should minimal residual disease negativity not be the end point of myeloma therapy?
|
Sonneveld, Pieter
|
|
|
|
8 |
p. 522-525
|
artikel
|
| 136 |
Singh A, Brandow AM, Panepinto JA. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 2021;5(7):1915-1921.
|
|
|
|
|
8 |
p. 2535
|
artikel
|
| 137 |
Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs
|
Masarova, Lucia
|
|
|
|
8 |
p. 2156-2164
|
artikel
|
| 138 |
SIPA in 10 milliseconds: VWF tentacles agglomerate and capture platelets under high shear
|
Liu, Zixiang Leonardo
|
|
|
|
8 |
p. 2453-2465
|
artikel
|
| 139 |
SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma
|
Yamamoto, Tomofumi
|
|
|
|
8 |
p. 2480-2495
|
artikel
|
| 140 |
Sphingosine 1-phosphate has a negative effect on RBC storage quality
|
Hay, Ariel
|
|
|
|
8 |
p. 1379-1393
|
artikel
|
| 141 |
Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism
|
Patel, Parth
|
|
|
|
8 |
p. 2237-2244
|
artikel
|
| 142 |
Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors
|
Abdel-Wahab, Noha
|
|
|
|
8 |
p. 1746-1755
|
artikel
|
| 143 |
Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia
|
Short, Nicholas J.
|
|
|
|
8 |
p. 1670-1677
|
artikel
|
| 144 |
Targeting the contact system in a rabbit model of extracorporeal membrane oxygenation
|
Tweddell, James S.
|
|
|
|
8 |
p. 1404-1417
|
artikel
|
| 145 |
The CLL comorbidity index in a population-based cohort: a tool for clinical care and research
|
Rotbain, Emelie C.
|
|
|
|
8 |
p. 2701-2706
|
artikel
|
| 146 |
The TAp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia
|
Laidou, Stamatia
|
|
|
|
8 |
p. 2646-2656
|
artikel
|
| 147 |
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis
|
Higham, Christine S.
|
|
|
|
8 |
p. 2106-2114
|
artikel
|
| 148 |
Treating lymphoma is now a bit EZ-er
|
Morin, Ryan D.
|
|
|
|
8 |
p. 2256-2263
|
artikel
|
| 149 |
Valoctocogene roxaparvovec gene transfer in participants with HIV
|
Ragni, Margaret V.
|
|
|
|
8 |
p. 1525-1530
|
artikel
|
| 150 |
van Rhee F, Rosenthal A, Kanhai K, et al. Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Adv. 2022;6(16):4773-4781.
|
|
|
|
|
8 |
p. 1604-1605
|
artikel
|
| 151 |
Vascular surgery patients with elevated neutrophil-to-lymphocyte ratios have downregulated neutrophil complement RNA expression
|
Chan, Ernest R.
|
|
|
|
8 |
p. 1446-1459
|
artikel
|
| 152 |
Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma
|
Yellapragada, Sarvari V.
|
|
|
|
8 |
p. 1643-1646
|
artikel
|
| 153 |
Zinc finger–IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell
|
Ochiai, Kyoko
|
|
|
|
8 |
p. 883-894
|
artikel
|
Tijdschrift beschrijving